143 related articles for article (PubMed ID: 33596896)
1. Effect of prior cancer on survival outcomes for patients with advanced prostate cancer.
Wu Y; Chen X; Qian D; Wang W; Zhang Y; Hu J; Zhu J; Wu Q; Cao T
BMC Urol; 2021 Feb; 21(1):26. PubMed ID: 33596896
[TBL] [Abstract][Full Text] [Related]
2. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract][Full Text] [Related]
3. Impact of prior cancer history on the survival of patients with larynx cancer.
Zhu K; Lin R; Zhang Z; Chen H; Rao X
BMC Cancer; 2020 Nov; 20(1):1137. PubMed ID: 33228622
[TBL] [Abstract][Full Text] [Related]
4. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
5. Impact of prior cancer history on the overall survival of younger patients with lung cancer.
Liu J; Zhou H; Zhang Y; Fang W; Yang Y; Hong S; Chen G; Zhao S; Chen X; Zhang Z; Xian W; Shen J; Huang Y; Zhao H; Zhang L
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32054633
[TBL] [Abstract][Full Text] [Related]
6. The impact of a prior malignancy on outcomes in gastric cancer patients.
Bian X; Wang K; Wang Q; Yang L; Xia J; Wu W; Li L
Cancer Med; 2021 Feb; 10(4):1457-1470. PubMed ID: 33470048
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
8. The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
Zhou Y; Guan H; Fu Y; Mao L; Ge J; Liu L; Cheng L; Guan C
Medicine (Baltimore); 2018 Dec; 97(50):e13479. PubMed ID: 30558003
[TBL] [Abstract][Full Text] [Related]
9. Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
Sun X; Li L; Xu L; Zhou Z; Chen J; Wang J; Zhang Y; Hu D; Chen M
BMC Cancer; 2021 Feb; 21(1):147. PubMed ID: 33563246
[TBL] [Abstract][Full Text] [Related]
10. Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study.
Ebad Ur Rehman M; Faraz F; Cheema HA; Ashruf OS; Raheel H; Naqvi SZA; Jabeen N; Abid A; Mumtaz Malik H; Iftikhar A; Ibrahim A; Swed S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1984. PubMed ID: 38389401
[TBL] [Abstract][Full Text] [Related]
11. Impact of prior cancer history on outcomes in thymoma: a propensity score, population-based study.
Wu S; Peng G; Liang W; He J
Gland Surg; 2021 May; 10(5):1618-1626. PubMed ID: 34164306
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
[TBL] [Abstract][Full Text] [Related]
13. Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.
Wang X; Wang Z; Chen Y; Lin Q; Chen H; Lin Y; Lu L; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103235. PubMed ID: 34563802
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes in esophageal cancer patients with a prior cancer.
Pan D; Xu W; Gao X; Yiyang F; Wei S; Zhu G
Medicine (Baltimore); 2021 Feb; 100(7):e24798. PubMed ID: 33607840
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
16. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
[TBL] [Abstract][Full Text] [Related]
17. Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed HH; Ibrahim Sokkar M; Afifi AM; Saad AM; Albarouki S; Al-Husseini MJ
J Obstet Gynaecol; 2020 Feb; 40(2):233-239. PubMed ID: 31352852
[TBL] [Abstract][Full Text] [Related]
18. Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria.
Al-Husseini MJ; Saad AM; Mohamed HH; Alkhayat MA; Sonbol MB; Abdel-Rahman O
BMC Cancer; 2019 Aug; 19(1):863. PubMed ID: 31470823
[TBL] [Abstract][Full Text] [Related]
19. Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.
Zhou H; Huang Y; Qiu Z; Zhao H; Fang W; Yang Y; Zhao Y; Hou X; Ma Y; Hong S; Zhou T; Zhang Y; Zhang L
Int J Cancer; 2018 Oct; 143(7):1569-1577. PubMed ID: 29667174
[TBL] [Abstract][Full Text] [Related]
20. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25667420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]